{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T02:00:51Z","timestamp":1769824851608,"version":"3.49.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00417-025-06756-2","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T15:35:56Z","timestamp":1738769756000},"page":"1489-1502","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Challenges and advances in ocular mucous membrane pemphigoid (OMMP); from pathogenesis to treatment strategies"],"prefix":"10.1007","volume":"263","author":[{"given":"Hamidreza","family":"Ghanbari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Momeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Aminizade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohreh","family":"Nozarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Moghtader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel E.","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayan","family":"Basu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virender S.","family":"Sangwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali R.","family":"Djalilian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6546-3546","authenticated-orcid":false,"given":"Mohammad","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"6756_CR1","first-page":"3379","volume":"20","author":"DC Branisteanu","year":"2020","unstructured":"Branisteanu DC, Stoleriu G, Branisteanu DE, Boda D, Branisteanu CI, Maranduca MA, Moraru A, Stanca HT, Zemba M, Balta F (2020) Ocular cicatricial pemphigoid. Exp Ther Med 20:3379\u20133382","journal-title":"Exp Ther Med"},{"key":"6756_CR2","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1001\/archderm.138.3.370","volume":"138","author":"LS Chan","year":"2002","unstructured":"Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ, Fine JD, Foster CS, Ghohestani R, Hashimoto T, Hoang-Xuan T, Kirtschig G, Korman NJ, Lightman S, Lozada-Nur F, Marinkovich MP, Mondino BJ, Prost-Squarcioni C, Rogers RS 3rd, Setterfield JF, West DP, Wojnarowska F, Woodley DT, Yancey KB, Zillikens D, Zone JJ (2002) The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 138:370\u2013379. https:\/\/doi.org\/10.1001\/archderm.138.3.370","journal-title":"Arch Dermatol"},{"key":"6756_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ophtha.2013.06.049","volume":"121","author":"SN Arafat","year":"2014","unstructured":"Arafat SN, Suelves AM, Spurr-Michaud S, Chodosh J, Foster CS, Dohlman CH, Gipson IK (2014) Neutrophil collagenase, gelatinase, and myeloperoxidase in tears of patients with Stevens-Johnson syndrome and ocular cicatricial pemphigoid. Ophthalmology 121:79\u201387","journal-title":"Ophthalmology"},{"key":"6756_CR4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/00130832-200410000-00017","volume":"4","author":"CS Foster","year":"2004","unstructured":"Foster CS, De La Maza MS (2004) Ocular cicatricial pemphigoid review. Curr Opin Allergy Clin Immunol 4:435\u2013439","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"6756_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ajo.2017.09.029","volume":"184","author":"N Aketa","year":"2017","unstructured":"Aketa N, Yamaguchi T, Asato T, Yagi-Yaguchi Y, Suzuki T, Higa K, Kurihara T, Satake Y, Tsubota K, Shimazaki J (2017) Elevated aqueous cytokine levels in eyes with ocular surface diseases. Am J Ophthalmol 184:42\u201351","journal-title":"Am J Ophthalmol"},{"key":"6756_CR6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","volume":"381","author":"E Schmidt","year":"2013","unstructured":"Schmidt E, Zillikens D (2013) Pemphigoid diseases. The Lancet 381:320\u2013332","journal-title":"The Lancet"},{"key":"6756_CR7","doi-asserted-by":"publisher","unstructured":"DaCosta J (2012) Ocular cicatricial pemphigoid masquerading as chronic conjunctivitis: a case report. Clin Ophthalmol 2093\u20132095. https:\/\/doi.org\/10.2147\/OPTH.S40319","DOI":"10.2147\/OPTH.S40319"},{"key":"6756_CR8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/BF00936519","volume":"231","author":"W Bernauer","year":"1993","unstructured":"Bernauer W, Wright P, Dart JK, Leonard JN, Lightman S (1993) Cytokines in the conjunctiva of acute and chronic mucous membrane pemphigoid: an immunohistochemical analysis. Graefes Arch Clin Exp Ophthalmol 231:563\u2013570","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"6756_CR9","first-page":"2283","volume":"40","author":"RY Chan","year":"1999","unstructured":"Chan RY, Bhol K, Tesavibul N, Letko E, Simmons RK, Foster CS, Ahmed AR (1999) The role of antibody to human \u03b24 integrin in conjunctival basement membrane separation: possible in vitro model for ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 40:2283\u20132290","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6756_CR10","first-page":"1449","volume":"15","author":"A Lambiase","year":"2009","unstructured":"Lambiase A, Micera A, Mantelli F, Moretti C, Di Zazzo A, Perrella E, Bonini S, Bonini S (2009) T-helper 17 lymphocytes in ocular cicatricial pemphigoid. Mol Vis 15:1449","journal-title":"Mol Vis"},{"key":"6756_CR11","doi-asserted-by":"publisher","first-page":"14714","DOI":"10.1073\/pnas.93.25.14714","volume":"93","author":"S Tyagi","year":"1996","unstructured":"Tyagi S, Bhol K, Natarajan K, Livir-Rallatos C, Foster C, Ahmed A (1996) Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization. Proc Natl Acad Sci 93:14714\u201314719","journal-title":"Proc Natl Acad Sci"},{"key":"6756_CR12","doi-asserted-by":"publisher","first-page":"11579","DOI":"10.1073\/pnas.88.24.11579","volume":"88","author":"AR Ahmed","year":"1991","unstructured":"Ahmed AR, Foster S, Zaltas M, Notani G, Awdeh Z, Alper CA, Yunis EJ (1991) Association of DQw7 (DQB1* 0301) with ocular cicatricial pemphigoid. Proc Natl Acad Sci 88:11579\u201311582","journal-title":"Proc Natl Acad Sci"},{"key":"6756_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/00003226-198201020-00005","volume":"1","author":"LW Hirst","year":"1982","unstructured":"Hirst LW, Werblin T, Novak M, Green WR, Pollack I (1982) Drug-induced cicatrizing conjunctivitis simulating ocular pemphigoid. Cornea 1:121\u2013128","journal-title":"Cornea"},{"key":"6756_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000003386","author":"Y Taketani","year":"2022","unstructured":"Taketani Y, Dehghani S, Sinha S, Freitag SK, Papaliodis G, Foster S, Dohlman TH, Dana R (2022) Concurrence of ocular cicatricial pemphigoid in chronic ocular graft-versus-host disease. Cornea. https:\/\/doi.org\/10.1097\/ICO.0000000000003386","journal-title":"Cornea"},{"key":"6756_CR15","doi-asserted-by":"publisher","unstructured":"Pflugfelder SC, Beuerman RW, Stern ME (2004) Dry eye and ocular surface disorders. (No Title). https:\/\/doi.org\/10.1201\/b14144","DOI":"10.1201\/b14144"},{"key":"6756_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/ICO.0000000000003382","volume":"43","author":"N Jain","year":"2024","unstructured":"Jain N, Jakati S, Shanbhag SS, Basu S (2024) Direct immunofluorescence findings and factors affecting conjunctival biopsy positivity in ocular mucous membrane pemphigoid. Cornea 43:159\u2013165","journal-title":"Cornea"},{"key":"6756_CR17","unstructured":"Benitez-del-Castillo JM, Lemp MA (2013) Ocular surface disorders. JP Medical Ltd"},{"key":"6756_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1684\/ejd.2016.2772","volume":"26","author":"X Li","year":"2016","unstructured":"Li X, Qian H, Sogame R, Hirako Y, Tsuruta D, Ishii N, Koga H, Tsuchisaka A, Jin Z, Tsubota K (2016) Integrin \u03b24 is a major target antigen in pure ocular mucous membrane pemphigoid. Eur J Dermatol 26:247\u2013253","journal-title":"Eur J Dermatol"},{"key":"6756_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/jdv.13397","volume":"30","author":"K Amber","year":"2016","unstructured":"Amber K, Bloom R, Hertl M (2016) A systematic review with pooled analysis of clinical presentation and immunodiagnostic testing in mucous membrane pemphigoid: association of anti-laminin-332 IgG with oropharyngeal involvement and the usefulness of ELISA. J Eur Acad Dermatol Venereol 30:72\u201377","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"6756_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3109\/08916934.2011.606447","volume":"45","author":"M Kasperkiewicz","year":"2012","unstructured":"Kasperkiewicz M, Zillikens D, Schmidt E (2012) Pemphigoid diseases: pathogenesis, diagnosis, and treatment. Autoimmunity 45:55\u201370","journal-title":"Autoimmunity"},{"key":"6756_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1001\/jamadermatol.2021.4773","volume":"158","author":"N Van Beek","year":"2022","unstructured":"Van Beek N, Kridin K, B\u00fchler E, Kochan AS, St\u00e4nder S, Ludwig RJ, Zillikens D, Schmidt E, G\u00fcnther C (2022) Evaluation of site-and autoantigen-specific characteristics of mucous membrane pemphigoid. JAMA Dermatol 158:84\u201389","journal-title":"JAMA Dermatol"},{"key":"6756_CR22","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/cup.12348","volume":"41","author":"DC Ding","year":"2014","unstructured":"Ding DC, Chu TY, Hsu YH (2014) Remission of anti-epiligrin cicatricial pemphigoid after excision of cervical adenocarcinoma. J Cutan Pathol 41:692\u2013693","journal-title":"J Cutan Pathol"},{"key":"6756_CR23","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3390\/biom12101461","volume":"12","author":"L Shi","year":"2022","unstructured":"Shi L, Li X, Qian H (2022) Anti-laminin 332-type mucous membrane pemphigoid. Biomolecules 12:1461","journal-title":"Biomolecules"},{"key":"6756_CR24","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1046\/j.1365-2133.1999.02773.x","volume":"140","author":"K Taniuchi","year":"1999","unstructured":"Taniuchi K, Takata M, Matsui C, Fushida Y, Uchiyama K, Mori T, Kawara S, Yancey K, Takehara K (1999) Antiepiligrin (laminin 5) cicatricial pemphigoid associated with an underlying gastric carcinoma producing laminin 5. Br J Dermatol 140:696\u2013700","journal-title":"Br J Dermatol"},{"key":"6756_CR25","doi-asserted-by":"publisher","unstructured":"Gitin A, Porta AD, Bisbee E, Braunlich K, Motaparthi K (2022) Anti-laminin 332 mucous membrane pemphigoid in a young woman treated with rituximab. Dermatol Online J 28. https:\/\/doi.org\/10.5070\/D328458517","DOI":"10.5070\/D328458517"},{"key":"6756_CR26","doi-asserted-by":"publisher","first-page":"775412","DOI":"10.3389\/fimmu.2021.775412","volume":"12","author":"L Bao","year":"2021","unstructured":"Bao L, Li J, Solimani F, Didona D, Patel PM, Li X, Qian H, Ishii N, Hashimoto T, Hertl M (2021) Subunit-specific reactivity of autoantibodies against laminin-332 reveals direct inflammatory mechanisms on keratinocytes. Front Immunol 12:775412","journal-title":"Front Immunol"},{"key":"6756_CR27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1006\/cyto.2002.1020","volume":"17","author":"M Razzaque","year":"2002","unstructured":"Razzaque M, Ahmed A (2002) Collagens, collagen-binding heat shock protein 47 and transforming growth factor-\u03b21 are induced in cicatricial pemphigoid: possible role (s) in dermal fibrosis. Cytokine 17:311\u2013316","journal-title":"Cytokine"},{"key":"6756_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1034\/j.1600-0714.2003.00028.x","volume":"32","author":"M Caproni","year":"2003","unstructured":"Caproni M, Calzolari A, Salvatore E, Giomi B, Volpi W, D\u2019Agata A, Santucci M, Fabbri P (2003) Cytokine profile and supposed contribution to scarring in cicatricial pemphigoid. J Oral Pathol Med 32:34\u201340","journal-title":"J Oral Pathol Med"},{"key":"6756_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ajpath.2010.11.013","volume":"178","author":"VP Saw","year":"2011","unstructured":"Saw VP, Schmidt E, Offiah I, Galatowicz G, Zillikens D, Dart JK, Calder VL, Daniels JT (2011) Profibrotic phenotype of conjunctival fibroblasts from mucous membrane pemphigoid. Am J Pathol 178:187\u2013197","journal-title":"Am J Pathol"},{"key":"6756_CR30","doi-asserted-by":"publisher","first-page":"e13190","DOI":"10.1111\/dth.13190","volume":"33","author":"R Russo","year":"2020","unstructured":"Russo R, Cozzani E, Gasparini G, Parodi A (2020) Targeting interleukin 4 receptor \u03b1: A new approach to the treatment of cutaneous autoimmune bullous diseases? Dermatol Ther 33:e13190","journal-title":"Dermatol Ther"},{"key":"6756_CR31","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.det.2011.03.011","volume":"29","author":"AS Kourosh","year":"2011","unstructured":"Kourosh AS, Yancey KB (2011) Pathogenesis of mucous membrane pemphigoid. Dermatol Clin 29:479\u2013484","journal-title":"Dermatol Clin"},{"key":"6756_CR32","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1167\/iovs.02-1084","volume":"44","author":"MS Razzaque","year":"2003","unstructured":"Razzaque MS, Ahmed BS, Foster CS, Ahmed AR (2003) Effects of IL-4 on conjunctival fibroblasts: possible role in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 44:3417\u20133423","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6756_CR33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ophtha.2007.04.027","volume":"115","author":"VP Saw","year":"2008","unstructured":"Saw VP, Dart JK, Rauz S, Ramsay A, Bunce C, Xing W, Maddison PG, Phillips M (2008) Immunosuppressive therapy for ocular mucous membrane pemphigoid: strategies and outcomes. Ophthalmology 115:253-261.e251","journal-title":"Ophthalmology"},{"key":"6756_CR34","doi-asserted-by":"publisher","first-page":"5310","DOI":"10.1167\/iovs.08-3345","volume":"50","author":"VP Saw","year":"2009","unstructured":"Saw VP, Dart RJ, Galatowicz G, Daniels JT, Dart JK, Calder VL (2009) Tumor necrosis factor-\u03b1 in ocular mucous membrane pemphigoid and its effect on conjunctival fibroblasts. Invest Ophthalmol Vis Sci 50:5310\u20135317","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6756_CR35","first-page":"1272","volume":"39","author":"A Lambiase","year":"1998","unstructured":"Lambiase A, Bonini S, Micera A, Rama P, Aloe L (1998) Expression of nerve growth factor receptors on the ocular surface in healthy subjects and during manifestation of inflammatory diseases. Invest Ophthalmol Vis Sci 39:1272\u20131275","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6756_CR36","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1111\/aos.14240","volume":"98","author":"A Bruscolini","year":"2020","unstructured":"Bruscolini A, Lambiase A, Segatto M, La Cava M, Nebbioso M, Sacchetti M (2020) Evaluation of IL 8 pathway on the ocular surface: new insights in patients with ocular mucous membrane pemphigoid. Acta Ophthalmol 98:e173\u2013e177","journal-title":"Acta Ophthalmol"},{"key":"6756_CR37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/exd.12883","volume":"25","author":"KN Messingham","year":"2016","unstructured":"Messingham KN, Wang JW, Holahan HM, Srikantha R, Aust SC, Fairley JA (2016) Eosinophil localization to the basement membrane zone is autoantibody-and complement-dependent in a human cryosection model of bullous pemphigoid. Exp Dermatol 25:50\u201355","journal-title":"Exp Dermatol"},{"key":"6756_CR38","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.2353\/ajpath.2009.090579","volume":"175","author":"VP Saw","year":"2009","unstructured":"Saw VP, Offiah I, Dart RJ, Galatowicz G, Dart JK, Daniels JT, Calder VL (2009) Conjunctival interleukin-13 expression in mucous membrane pemphigoid and functional effects of interleukin-13 on conjunctival fibroblasts in vitro. Am J Pathol 175:2406\u20132415","journal-title":"Am J Pathol"},{"key":"6756_CR39","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/path.1674","volume":"204","author":"I Shimanovich","year":"2004","unstructured":"Shimanovich I, Mihai S, Oostingh GJ, Ilenchuk TT, Br\u00f6cker EB, Opdenakker G, Zillikens D, Sitaru C (2004) Granulocyte-derived elastase and gelatinase B are required for dermal\u2013epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. J Pathol: J Pathol Soc Great Brit Ireland 204:519\u2013527","journal-title":"J Pathol: J Pathol Soc Great Brit Ireland"},{"key":"6756_CR40","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1038\/s41598-020-59237-3","volume":"10","author":"AM Woodward","year":"2020","unstructured":"Woodward AM, Di Zazzo A, Bonini S, Arg\u00fceso P (2020) Endoplasmic reticulum stress promotes inflammation-mediated proteolytic activity at the ocular surface. Sci Rep 10:2216","journal-title":"Sci Rep"},{"key":"6756_CR41","doi-asserted-by":"publisher","first-page":"342","DOI":"10.4103\/0019-5154.74536","volume":"55","author":"D Aksu","year":"2010","unstructured":"Aksu D, Peksari Y, Arica IE, Gurgey E (2010) Assessing the autoantibody levels in relation to disease severity and therapy response in pemphigus patients. Indian J Dermatol 55:342\u2013347","journal-title":"Indian J Dermatol"},{"key":"6756_CR42","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1080\/08820130902943097","volume":"38","author":"A Satyam","year":"2009","unstructured":"Satyam A, Khandpur S, Sharma V, Sharma A (2009) Involvement of TH1\/TH2 cytokines in the pathogenesis of autoimmune skin disease\u2014pemphigus vulgaris. Immunol Invest 38:498\u2013509","journal-title":"Immunol Invest"},{"key":"6756_CR43","doi-asserted-by":"publisher","unstructured":"Bernauer W, Dart JK, Elder MJ (1997) Cicatrising conjunctivitis. Karger Medical and Scientific Publishers. https:\/\/doi.org\/10.1159\/isbn.978-3-318-00231-7","DOI":"10.1159\/isbn.978-3-318-00231-7"},{"key":"6756_CR44","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S0161-6420(89)32922-8","volume":"96","author":"EH Sacks","year":"1989","unstructured":"Sacks EH, Jakobiec FA, Wieczorek R, Donnenfeld E, Perry H, Knowles DM Jr (1989) Immunophenotypic analysis of the inflammatory infiltrate in ocular cicatricial pemphigoid: further evidence for a T cell-mediated disease. Ophthalmology 96:236\u2013243","journal-title":"Ophthalmology"},{"key":"6756_CR45","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jtos.2023.09.005","volume":"30","author":"J Panthagani","year":"2023","unstructured":"Panthagani J, Suleiman K, Vincent RC, Ong HS, Wallace GR, Rauz S (2023) Conjunctival transcriptomics in ocular mucous membrane pemphigoid. Ocul Surf 30:142\u2013149","journal-title":"Ocul Surf"},{"key":"6756_CR46","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/pde.13971","volume":"36","author":"V Flores-Climente","year":"2019","unstructured":"Flores-Climente V, Rozas-Mu\u00f1oz E, Mart\u00ednez-Grau A, Aucouturier F, Luna S, Baselga E (2019) Childhood ocular mucous membrane pemphigoid successfully treated with rituximab. Pediatr Dermatol 36:984\u2013985","journal-title":"Pediatr Dermatol"},{"key":"6756_CR47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.reumae.2020.10.003","volume":"18","author":"AM Smichowski","year":"2022","unstructured":"Smichowski AM, Caputo VD, Romeo C, Rivero E, Morales NS, Casado G (2022) Ocular cicatricial pemphigoid: methotrexate as an initial treatment? Reumatol Cl\u00edn (English Edition) 18:30\u201332","journal-title":"Reumatol Cl\u00edn (English Edition)"},{"key":"6756_CR48","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.ophtha.2005.01.039","volume":"112","author":"S Rauz","year":"2005","unstructured":"Rauz S, Maddison PG, Dart JK (2005) Evaluation of mucous membrane pemphigoid with ocular involvement in young patients. Ophthalmology 112:1268\u20131274","journal-title":"Ophthalmology"},{"key":"6756_CR49","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.jid.2023.02.012","volume":"143","author":"JA Fairley","year":"2023","unstructured":"Fairley JA, Crowe TP, Fakhimi M, Palmer SJ, Greiner MA, Hellstein JW, Van Daele DJ, Messingham KN (2023) Disease endotypes predict the severity of mucous membrane pemphigoid. J Invest Dermatol 143:1479-1486.e1473","journal-title":"J Invest Dermatol"},{"key":"6756_CR50","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41415-024-7074-8","volume":"236","author":"G Davis","year":"2024","unstructured":"Davis G, Hathway R, Shipley D, Staines K (2024) The management of pemphigus vulgaris and mucous membrane pemphigoid in a joint oral medicine and dermatology clinic: a five-year narrative review. Br Dent J 236:311\u2013316","journal-title":"Br Dent J"},{"key":"6756_CR51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ophtha.2003.03.001","volume":"111","author":"JE Thorne","year":"2004","unstructured":"Thorne JE, Anhalt GJ, Jabs DA (2004) Mucous membrane pemphigoid and pseudopemphigoid. Ophthalmology 111:45\u201352","journal-title":"Ophthalmology"},{"key":"6756_CR52","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.preteyeres.2004.05.005","volume":"23","author":"M Ahmed","year":"2004","unstructured":"Ahmed M, Zein G, Khawaja F, Foster CS (2004) Ocular cicatricial pemphigoid: pathogenesis, diagnosis and treatment. Prog Retin Eye Res 23:579\u2013592","journal-title":"Prog Retin Eye Res"},{"key":"6756_CR53","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11882-005-0078-9","volume":"5","author":"JH Chang","year":"2005","unstructured":"Chang JH, McCluskey PJ (2005) Ocular cicatricial pemphigoid: manifestations and management. Curr Allergy Asthma Rep 5:333\u2013338","journal-title":"Curr Allergy Asthma Rep"},{"key":"6756_CR54","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/eye.1994.45","volume":"8","author":"MJ Elder","year":"1994","unstructured":"Elder MJ, Lightman S (1994) The immunological features and pathophysiology of ocular cicatricial pemphigoid. Eye 8:196\u2013199","journal-title":"Eye"},{"key":"6756_CR55","first-page":"527","volume":"84","author":"CS Foster","year":"1986","unstructured":"Foster CS (1986) Cicatricial pemphigoid. Trans Am Ophthalmol Soc 84:527","journal-title":"Trans Am Ophthalmol Soc"},{"key":"6756_CR56","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ophtha.2018.01.014","volume":"125","author":"T Margolis","year":"2018","unstructured":"Margolis T (2018) Evidence-based insights into the utility of conjunctival biopsy in mucous membrane pemphigoid. Ophthalmology 125:474\u2013475","journal-title":"Ophthalmology"},{"key":"6756_CR57","first-page":"S34","volume":"29","author":"J-u Mughal","year":"2019","unstructured":"Mughal J-u, Muhammad AJ, Erum U (2019) Ocular cicatricial pemphigoid: camouflaged as persistent conjunctivitis. JCPSP 29:S34\u2013S36","journal-title":"JCPSP"},{"key":"6756_CR58","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1111\/jdv.17397","volume":"35","author":"H Rashid","year":"2021","unstructured":"Rashid H, Lamberts A, Borradori L, Alberti-Violetti S, Barry R, Caproni M, Carey B, Carrozzo M, Caux F, Cianchini G (2021) European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology-Part I. J Eur Acad Dermatol Venereol 35:1750\u20131764","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"6756_CR59","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1097\/ico.0000000000003324","volume":"42","author":"C Singh","year":"2023","unstructured":"Singh C, Jain N, Sharma S, Basu S, Shanbhag SS (2023) Vortex keratopathy as a presenting feature of ocular mucous membrane pemphigoid. Cornea 42:1454\u20131457. https:\/\/doi.org\/10.1097\/ico.0000000000003324","journal-title":"Cornea"},{"key":"6756_CR60","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0161-6420(81)35069-6","volume":"88","author":"BJ Mondino","year":"1981","unstructured":"Mondino BJ, Brown SI (1981) Ocular cicatricial pemphigoid. Ophthalmology 88:95\u2013100","journal-title":"Ophthalmology"},{"key":"6756_CR61","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1365-4362.1986.tb04544.x","volume":"25","author":"AR Ahmed","year":"1986","unstructured":"Ahmed AR, Hombal SM (1986) Cicatricial pemphigoid. Int J Dermatol 25:90\u201396","journal-title":"Int J Dermatol"},{"key":"6756_CR62","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0161-6420(79)35486-0","volume":"86","author":"BJ Mondino","year":"1979","unstructured":"Mondino BJ, Brown SI, Lempert S, Jenkins MS (1979) The acute manifestations of ocular cicatricial pemphigoid: diagnosis and treatment. Ophthalmology 86:543\u2013552","journal-title":"Ophthalmology"},{"key":"6756_CR63","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/eye.2016.284","volume":"31","author":"JK Dart","year":"2017","unstructured":"Dart JK (2017) The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on. Eye 31:301\u2013332","journal-title":"Eye"},{"key":"6756_CR64","doi-asserted-by":"publisher","first-page":"226","DOI":"10.22336\/rjo.2020.38","volume":"64","author":"C Stan","year":"2020","unstructured":"Stan C, Diaconu E, Hopirca L, Petra N, Rednic A, Stan C (2020) Ocular cicatricial pemphigoid. Rom J Ophthalmol 64:226\u2013230","journal-title":"Rom J Ophthalmol"},{"key":"6756_CR65","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1136\/bjo.80.4.292","volume":"80","author":"MJ Elder","year":"1996","unstructured":"Elder MJ, Bernauer W, Leonard J, Dart J (1996) Progression of disease in ocular cicatricial pemphigoid. Br J Ophthalmol 80:292\u2013296","journal-title":"Br J Ophthalmol"},{"key":"6756_CR66","first-page":"1530","volume":"20","author":"SC Hofmann","year":"2022","unstructured":"Hofmann SC, G\u00fcnther C, B\u00f6ckle BC, Didona D, Ehrchen J, Gaskins M, Geerling G, Gl\u00e4ser R, Hadaschik E, Hampl M (2022) S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 20:1530\u20131550","journal-title":"JDDG: Journal der Deutschen Dermatologischen Gesellschaft"},{"key":"6756_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2024.02.028","author":"RE Ruiz-Lozano","year":"2024","unstructured":"Ruiz-Lozano RE, Colorado-Zavala MF, Ramos-D\u00e1vila EM, Quiroga-Garza ME, Azar NS, Mousa HM, Hern\u00e1ndez-Camarena JC, Stinnett SS, Daluvoy M, Kim T, Sainz-de-la-Maza M, Hall RP, Rodriguez-Garcia A, Perez VL (2024) Ocular mucous membrane pemphigoid: the effect of risk factors at presentation on treatment outcomes. Ophthalmology. https:\/\/doi.org\/10.1016\/j.ophtha.2024.02.028","journal-title":"Ophthalmology"},{"key":"6756_CR68","first-page":"611","volume":"57","author":"H-H Xu","year":"2013","unstructured":"Xu H-H, Werth VP, Parisi E, Sollecito TP (2013) Mucous membrane pemphigoid. Dent Clin 57:611\u2013630","journal-title":"Dent Clin"},{"key":"6756_CR69","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1097\/IOP.0000000000002021","volume":"37","author":"S Besagar","year":"2021","unstructured":"Besagar S, London AO, Jairam MP, Trief D, Glass LRD (2021) Chronic early-stage ocular cicatricial pemphigoid. Ophthal Plast Reconstr Surg 37:e209\u2013e213","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"6756_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2020.01.033","volume":"216","author":"G Coco","year":"2020","unstructured":"Coco G, Romano V, Menassa N, Borroni D, Iselin K, Finn D, Figueiredo GS, Tacea F, Field EA, Ahmad S (2020) Conjunctival biopsy site in mucous membrane pemphigoid. Am J Ophthalmol 216:1\u20136","journal-title":"Am J Ophthalmol"},{"key":"6756_CR71","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/01.all.0000244799.33734.d4","volume":"6","author":"M Hingorani","year":"2006","unstructured":"Hingorani M, Lightman S (2006) Ocular cicatricial pemphigoid. Curr Opin Allergy Clin Immunol 6:373\u2013378","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"6756_CR72","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ajo.2017.08.009","volume":"183","author":"MT Labowsky","year":"2017","unstructured":"Labowsky MT, Stinnett SS, Liss J, Daluvoy M, Hall RP III, Shieh C (2017) Clinical implications of direct immunofluorescence findings in patients with ocular mucous membrane pemphigoid. Am J Ophthalmol 183:48\u201355","journal-title":"Am J Ophthalmol"},{"key":"6756_CR73","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1097\/ICO.0000000000003235","volume":"42","author":"AM Philip","year":"2023","unstructured":"Philip AM, Stephenson A, Al-Dabbagh A, Ramezani K, Fernandez-Santos CC, Foster CS (2023) Ocular cicatricial pemphigoid with IgM-positive biopsy. Cornea 42:1503\u20131505","journal-title":"Cornea"},{"key":"6756_CR74","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1136\/annrheumdis-2023-eular.5549","volume":"82","author":"A Ringer","year":"2023","unstructured":"Ringer A, Smichowski AM, Siegrist C, Grossi DG, Delpiaz MS, Caballero S, Gomez R, Sa CF, Chulibert S, Abdala B, Abdala M, Martini M, Segretin E, Gandino I (2023) Conjunctival biopsy in ocular cicatricial pemphigoid, are there patterns to predict sequelae? Ann Rheum Dis 82:1975. https:\/\/doi.org\/10.1136\/annrheumdis-2023-eular.5549","journal-title":"Ann Rheum Dis"},{"key":"6756_CR75","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/S0161-6420(95)30896-2","volume":"102","author":"WJ Power","year":"1995","unstructured":"Power WJ, Neves RA, Rodriguez A, Dutt JE, Foster CS (1995) Increasing the diagnostic yield of conjunctival biopsy in patients with suspected ocular cicatricia1 pemphigoid. Ophthalmology 102:1158\u20131163","journal-title":"Ophthalmology"},{"key":"6756_CR76","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1080\/09273948.2020.1716988","volume":"29","author":"SD Anesi","year":"2021","unstructured":"Anesi SD, Eggenschwiler L, Ferrara M, Artornsombudh P, Walsh M, Foster CS (2021) Reliability of conjunctival biopsy for diagnosis of ocular mucous membrane pemphigoid: redetermination of the standard for diagnosis and outcomes of previously biopsy-negative patients. Ocul Immunol Inflamm 29:1106\u20131113","journal-title":"Ocul Immunol Inflamm"},{"key":"6756_CR77","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.ophtha.2022.06.001","volume":"129","author":"SN Lopez","year":"2022","unstructured":"Lopez SN, Cao J, de Leon SC, Dominguez AR (2022) Utility of direct immunofluorescence using Buccal mucosal biopsies in those with suspected isolated ocular mucous membrane pemphigoid. Ophthalmology 129:1171\u20131176","journal-title":"Ophthalmology"},{"key":"6756_CR78","first-page":"1004","volume":"17","author":"MA Ilie","year":"2019","unstructured":"Ilie MA, Caruntu C, Lixandru D, Tampa M, Georgescu SR, Constantin MM, Constantin C, Neagu M, Zurac SA, Boda D (2019) In vivo confocal laser scanning microscopy imaging of skin inflammation: Clinical applications and research directions. Exp Ther Med 17:1004\u20131011","journal-title":"Exp Ther Med"},{"key":"6756_CR79","first-page":"4102","volume":"17","author":"MA Ilie","year":"2019","unstructured":"Ilie MA, Caruntu C, Lupu M, Lixandru D, Tampa M, Georgescu S-R, Bastian A, Constantin C, Neagu M, Zurac SA (2019) Current and future applications of confocal laser scanning microscopy imaging in skin oncology. Oncol Lett 17:4102\u20134111","journal-title":"Oncol Lett"},{"key":"6756_CR80","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1006\/cyto.2001.0877","volume":"14","author":"S Kumari","year":"2001","unstructured":"Kumari S, Bhol KC, Rehman F, Foster CS, Ahmed AR (2001) Interleukin 1 components in cicatricial pemphigoid. Role in intravenous immunoglobulin therapy. Cytokine 14:218\u2013224","journal-title":"Cytokine"},{"key":"6756_CR81","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00417-002-0497-4","volume":"240","author":"E Letko","year":"2002","unstructured":"Letko E, Bhol K, Colon J, Foster SC, Ahmed RA (2002) Biology of interleukin-5 in ocular cicatricial pemphigoid. Graefes Arch Clin Exp Ophthalmol 240:565\u2013569","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"6756_CR82","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1167\/iovs.64.15.17","volume":"64","author":"A Di Zazzo","year":"2023","unstructured":"Di Zazzo A, Cutrupi F, De Antoniis MG, Ricci M, Esposito G, Antonini M, Coassin M, Micera A, Perrella E, Bonini S (2023) Tissue remodeling in ocular mucous membrane pemphigoid. Invest Ophthalmol Vis Sci 64:17\u201317","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6756_CR83","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/j.jcjo.2022.11.011","volume":"59","author":"M Lin","year":"2024","unstructured":"Lin M, Boonsopon S, Manhapra A, Zhao T, Foster CS (2024) Elevated serum BAFF in patients with ocular cicatricial pemphigoid. Can J Ophthalmol 59:e105\u2013e110","journal-title":"Can J Ophthalmol"},{"key":"6756_CR84","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1111\/jdv.17395","volume":"35","author":"E Schmidt","year":"2021","unstructured":"Schmidt E, Rashid H, Marzano AV, Lamberts A, Di Zenzo G, Diercks GFH, Alberti-Violetti S, Barry RJ, Borradori L, Caproni M, Carey B, Carrozzo M, Cianchini G, Corr\u00e0 A, Dikkers FG, Feliciani C, Geerling G, Genovese G, Hertl M, Joly P, Meijer JM, Mercadante V, Murrell DF, Ormond M, Pas HH, Patsatsi A, Rauz S, van Rhijn BD, Roth M, Setterfield J, Zillikens D, Prost C, Zambruno G, Horv\u00e1th B, Caux F (2021) European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II. J Eur Acad Dermatol Venereol 35:1926\u20131948. https:\/\/doi.org\/10.1111\/jdv.17395","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"6756_CR85","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jtos.2022.02.004","volume":"24","author":"S Singh","year":"2022","unstructured":"Singh S, Donthineni PR, Shanbhag SS, Senthil S, Ong HS, Dart JK, Basu S (2022) Drug induced cicatrizing conjunctivitis: a case series with review of etiopathogenesis, diagnosis and management. Ocul Surf 24:83\u201392. https:\/\/doi.org\/10.1016\/j.jtos.2022.02.004","journal-title":"Ocul Surf"},{"key":"6756_CR86","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0002-9394(14)75950-1","volume":"85","author":"A Flach","year":"1978","unstructured":"Flach A (1978) Symblepharon in sarcoidosis. Am J Ophthalmol 85:210\u2013214","journal-title":"Am J Ophthalmol"},{"key":"6756_CR87","first-page":"109","volume":"54","author":"B Jones","year":"1961","unstructured":"Jones B (1961) The ocular diagnosis of benign mucous membrane pemphigoid. Proc R Soc Med 54:109\u2013110","journal-title":"Proc R Soc Med"},{"key":"6756_CR88","doi-asserted-by":"crossref","unstructured":"Cifuentes-Gonz\u00e1lez C, Amaris-Mart\u00ednez S, Reyes-Guanes J, Uribe-Reina P, De-la-Torre A (2022) Ocular cicatricial pemphigoid, sj\u00f6gren\u2019s syndrome, and hashimoto\u2019s thyroiditis as a multiple autoimmune syndrome: a case report. Eur J Ophthalmol 32:NP52-NP55","DOI":"10.1177\/1120672121996637"},{"key":"6756_CR89","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/ICO.0000000000003056","volume":"42","author":"AM Philip","year":"2023","unstructured":"Philip AM, Fernandez-Santos CC, Ramezani K, Dolinko AH, Manhapra A, Look-Why S, Chang PY, Foster CS, Anesi SD (2023) Ocular mucus membrane pemphigoid: a primary versus secondary entity. Cornea 42:280\u2013283","journal-title":"Cornea"},{"key":"6756_CR90","doi-asserted-by":"publisher","unstructured":"Ringer A, Smichowski AM, G\u00f3mez R, Virasoro B, Mart\u00ednez L, Bertiller E, Siegrist C, Abdala B, Chulibert S, Grossi G, Rub\u00edn E, Kostianovsky A, Mu\u00f1oz SA, Lutgen S, Gandino IJ (2024) Ocular cicatricial pemphigoid: is there an association with autoimmune diseases? Int Ophthalmol 44. https:\/\/doi.org\/10.1007\/s10792-024-02939-8","DOI":"10.1007\/s10792-024-02939-8"},{"key":"6756_CR91","doi-asserted-by":"publisher","first-page":"338","DOI":"10.4274\/tjo.galenos.2021.05031","volume":"51","author":"FL Sa\u00e1","year":"2021","unstructured":"Sa\u00e1 FL, Cremona F, Chiaradia P (2021) Association between skin findings and ocular signs in rosacea. Turk J Ophthalmol 51:338","journal-title":"Turk J Ophthalmol"},{"key":"6756_CR92","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.ophtha.2009.09.006","volume":"117","author":"AE Ahuero","year":"2010","unstructured":"Ahuero AE, Jakobiec FA, Bhat P, Ciralsky JB, Papaliodis GN (2010) Paraneoplastic conjunctival cicatrization: two different pathogenic types. Ophthalmology 117:659\u2013664. https:\/\/doi.org\/10.1016\/j.ophtha.2009.09.006","journal-title":"Ophthalmology"},{"key":"6756_CR93","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ophtha.2009.06.060","volume":"117","author":"SS Pujari","year":"2010","unstructured":"Pujari SS, Kempen JH, Newcomb CW, Gangaputra S, Daniel E, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB (2010) Cyclophosphamide for ocular inflammatory diseases. Ophthalmology 117:356\u2013365","journal-title":"Ophthalmology"},{"key":"6756_CR94","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2147\/TCRM.S1140","volume":"4","author":"AG Neff","year":"2008","unstructured":"Neff AG, Turner M, Mutasim DF (2008) Treatment strategies in mucous membrane pemphigoid. Ther Clin Risk Manag 4:617\u2013626","journal-title":"Ther Clin Risk Manag"},{"key":"6756_CR95","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/11206721231178110","volume":"34","author":"S Moussa","year":"2024","unstructured":"Moussa S, Tong M, Robert M-C, Harissi-Dagher M, Ahmad S, Jabbour S (2024) Survey: preferred practice patterns in the diagnosis of mucous membrane pemphigoid amongst cornea specialists. Eur J Ophthalmol 34:112\u2013118","journal-title":"Eur J Ophthalmol"},{"key":"6756_CR96","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/ICO.0000000000003071","volume":"42","author":"KB Johnson","year":"2023","unstructured":"Johnson KB, Rosenbaum JT, Yarter JT, Broadbent T, Michels KS (2023) A 10-year review of the management of ocular mucous membrane pemphigoid: a private practice experience. Cornea 42:565\u2013571","journal-title":"Cornea"},{"key":"6756_CR97","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1097\/ICO.0000000000002080","volume":"38","author":"F Fremont","year":"2019","unstructured":"Fremont F, Pelissier-Suarez C, Fourni\u00e9 P, Porterie M, Thevenin A, Astudillo L, Paricaud K, Gualino V, Soler V, Pugnet G (2019) Clinical characteristics and outcomes of ocular cicatricial pemphigoid: a cohort study and literature review. Cornea 38:1406\u20131411","journal-title":"Cornea"},{"key":"6756_CR98","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4274\/tjo.galenos.2022.34683","volume":"53","author":"MD \u00c7ift\u00e7i","year":"2023","unstructured":"\u00c7ift\u00e7i MD, Korkmaz \u0130, Palamar M, Yaman B, E\u011frilmez S, Ya\u011fc\u0131 A, Akal\u0131n T, Selver \u00d6B (2023) Clinical approach to ocular cicatricial pemphigoid. Turk J Ophthalmol 53:79","journal-title":"Turk J Ophthalmol"},{"key":"6756_CR99","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.tjo.2015.03.004","volume":"5","author":"DM Hornbeak","year":"2015","unstructured":"Hornbeak DM, Thorne JE (2015) Immunosuppressive therapy for eye diseases: effectiveness, safety, side effects and their prevention. Taiwan J Ophthalmol 5:156\u2013163","journal-title":"Taiwan J Ophthalmol"},{"key":"6756_CR100","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.ophtha.2003.07.010","volume":"111","author":"P McCluskey","year":"2004","unstructured":"McCluskey P, Chang JH, Singh R, Wakefield D (2004) Methotrexate therapy for ocular cicatricial pemphigoid. Ophthalmology 111:796\u2013801","journal-title":"Ophthalmology"},{"key":"6756_CR101","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1097\/ICO.0000000000000168","volume":"33","author":"J Friedman","year":"2014","unstructured":"Friedman J, Marcovich AL, Kleinmann G, Schattner A (2014) Low-dose pulsed intravenous cyclophosphamide for severe ocular cicatricial pemphigoid in elderly patients. Cornea 33:1066\u20131070","journal-title":"Cornea"},{"key":"6756_CR102","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1076\/0271-3683(200008)2121-VFT646","volume":"21","author":"E Letko","year":"2000","unstructured":"Letko E, Bhol K, Foster CS, Ahmed AR (2000) Influence of intravenous immunoglobulin therapy on serum levels of anti-\u00df4 antibodies in ocular cicatricial pemphigoid: a correlation with disease activity. Curr Eye Res 21:646\u2013654","journal-title":"Curr Eye Res"},{"key":"6756_CR103","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.ophtha.2009.09.049","volume":"117","author":"CS Foster","year":"2010","unstructured":"Foster CS, Chang PY, Ahmed AR (2010) Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report. Ophthalmology 117:861\u2013869","journal-title":"Ophthalmology"},{"key":"6756_CR104","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1684\/ejd.2021.4132","volume":"32","author":"MS Alrashdan","year":"2022","unstructured":"Alrashdan MS, Kamaguchi M (2022) Management of mucous membrane pemphigoid: a literature review and update. Eur J Dermatol 32:312\u2013321","journal-title":"Eur J Dermatol"},{"key":"6756_CR105","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ajo.2020.09.029","volume":"223","author":"AS Shifera","year":"2021","unstructured":"Shifera AS, Hong GH, Khan IR, Okeagu C, Thorne JE (2021) Disease relapse after drug-free remission in ocular mucous membrane pemphigoid. Am J Ophthalmol 223:21\u201327","journal-title":"Am J Ophthalmol"},{"key":"6756_CR106","doi-asserted-by":"publisher","first-page":"e273","DOI":"10.1016\/j.jaad.2022.02.017","volume":"86","author":"KA Sprague","year":"2022","unstructured":"Sprague KA, Sivesind TE, Szeto MD, Dellavalle RP, Kirtschig G (2022) From the Cochrane Library: Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita. J Am Acad Dermatol 86:e273\u2013e274","journal-title":"J Am Acad Dermatol"},{"key":"6756_CR107","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1097\/ICO.0000000000002683","volume":"40","author":"SL Bevans","year":"2021","unstructured":"Bevans SL, Parker J, Ivey JM, Pavlidakey P, Sami N (2021) Rituximab as an adjuvant rescue treatment for ocular cicatricial pemphigoid. Cornea 40:1440\u20131444","journal-title":"Cornea"},{"key":"6756_CR108","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.ophtha.2003.11.012","volume":"111","author":"N Sami","year":"2004","unstructured":"Sami N, Letko E, Androudi S, Daoud Y, Foster CS, Ahmed AR (2004) Intravenous immunoglobulin therapy in patients with Ocular-Cicatricial pemphigoid: a long-term follow-up. Ophthalmology 111:1380\u20131382","journal-title":"Ophthalmology"},{"key":"6756_CR109","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/exd.14829","volume":"32","author":"N Kianfar","year":"2023","unstructured":"Kianfar N, Dasdar S, Daneshpazhooh M, Aryanian Z, Goodarzi A (2023) A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: special focus on indication and combination therapy. Exp Dermatol 32:934\u2013944","journal-title":"Exp Dermatol"},{"key":"6756_CR110","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jaad.2020.12.056","volume":"87","author":"Y Lytvyn","year":"2022","unstructured":"Lytvyn Y, Rahat S, Mufti A, Witol A, Bagit A, Sachdeva M, Yeung J (2022) Biologic treatment outcomes in mucous membrane pemphigoid: a systematic review. J Am Acad Dermatol 87:110\u2013120","journal-title":"J Am Acad Dermatol"},{"key":"6756_CR111","doi-asserted-by":"crossref","unstructured":"Bedane C, Prost C, Ingen-Housz-Oro S, Joly P, Bernard P (2011) Mucous membrane pemphigoid. Guidelines for the diagnosis and treatment. Centres de r\u00e9f\u00e9rence des maladies bulleuses auto-immunes. Soci\u00e9t\u00e9 Fran\u00e7aise de DermatologieAnnales de Dermatologie et de Venereologie, pp. 259\u2013263.","DOI":"10.1016\/j.annder.2011.01.014"},{"key":"6756_CR112","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1001\/archderm.138.3.370","volume":"138","author":"LS Chan","year":"2002","unstructured":"Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ, Fine J-D, Foster CS, Ghohestani R, Hashimoto T (2002) The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 138:370\u2013379","journal-title":"Arch Dermatol"},{"key":"6756_CR113","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1016\/j.ophtha.2008.08.002","volume":"115","author":"JE Thorne","year":"2008","unstructured":"Thorne JE, Woreta FA, Jabs DA, Anhalt GJ (2008) Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy. Ophthalmology 115:2146-2152.e2141","journal-title":"Ophthalmology"},{"key":"6756_CR114","doi-asserted-by":"publisher","first-page":"10","DOI":"10.21037\/aes-22-41","volume":"9","author":"C Castiblanco","year":"2024","unstructured":"Castiblanco C (2024) Ocular cicatricial pemphigoid: diagnosis and systemic management. Ann Eye Sci 9:10\u201310","journal-title":"Ann Eye Sci"},{"key":"6756_CR115","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/bjophthalmol-2020-318092","volume":"106","author":"R Deshmukh","year":"2022","unstructured":"Deshmukh R, Ting DSJ, Elsahn A, Mohammed I, Said DG, Dua HS (2022) Real-world experience of using ciclosporin-A 0.1% in the management of ocular surface inflammatory diseases. Br J Ophthalmol 106:1087\u20131092","journal-title":"Br J Ophthalmol"},{"key":"6756_CR116","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ajoc.2018.03.018","volume":"10","author":"Y Sharon","year":"2018","unstructured":"Sharon Y, Chu DS (2018) Adrenocorticotropic hormone analogue as novel treatment regimen in ocular cicatricial pemphigoid. Am J Ophthalmol Case Rep 10:264\u2013267","journal-title":"Am J Ophthalmol Case Rep"},{"key":"6756_CR117","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/ICO.0b013e3181ae2691","volume":"29","author":"G Iyer","year":"2010","unstructured":"Iyer G, Pillai VS, Srinivasan B, Guruswami S, Padmanabhan P (2010) Mucous membrane grafting for lid margin keratinization in Stevens-Johnson syndrome: results. Cornea 29:146\u2013151","journal-title":"Cornea"},{"key":"6756_CR118","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40123-019-0164-z","volume":"8","author":"P Georgoudis","year":"2019","unstructured":"Georgoudis P, Sabatino F, Szentmary N, Palioura S, Fodor E, Hamada S, Scholl HP, Gatzioufas Z (2019) Ocular mucous membrane pemphigoid: current state of pathophysiology, diagnostics and treatment. Ophthalmol Ther 8:5\u201317","journal-title":"Ophthalmol Ther"},{"key":"6756_CR119","doi-asserted-by":"crossref","unstructured":"Higuchi A (2018) Autologous serum and serum components. Invest Ophthalmol Vis Sci 59:DES121-DES129","DOI":"10.1167\/iovs.17-23760"},{"key":"6756_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09273948.2024.2413892","volume":"32","author":"KS Abbott","year":"2024","unstructured":"Abbott KS, Palestine AG, Hauswirth SG, Gregory DG, Patnaik JL, Reddy AK (2024) Treatment of ocular surface disease in ocular cicatricial pemphigoid. Ocul Immunol Inflamm 32:1\u20137","journal-title":"Ocul Immunol Inflamm"},{"key":"6756_CR121","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s40265-022-01782-4","volume":"82","author":"JE Frampton","year":"2022","unstructured":"Frampton JE (2022) Varenicline solution nasal spray: a review in dry eye disease. Drugs 82:1481\u20131488","journal-title":"Drugs"},{"key":"6756_CR122","doi-asserted-by":"publisher","unstructured":"DeGrazia T, Bromley J, Feldman R (2019) Bilateral keratoprostheses in a patient with ocular mucous membrane pemphigoid. Dermatol Online J 25. https:\/\/doi.org\/10.5070\/D32511046149","DOI":"10.5070\/D32511046149"},{"key":"6756_CR123","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/ICO.0000000000002932","volume":"41","author":"R Ollero","year":"2022","unstructured":"Ollero R, Soldevila A, de la Paz MF, Mart\u00ednez-Grau A (2022) Surgical management of ocular cicatricial pemphigoid in a pediatric patient. Cornea 41:911\u2013913","journal-title":"Cornea"},{"key":"6756_CR124","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.ajo.2015.01.028","volume":"159","author":"A Gibbons","year":"2015","unstructured":"Gibbons A, Johnson TE, Wester ST, Gonzalez AE, Farias CC, Betancurt C, Amescua G, Perez VL (2015) Management of patients with confirmed and presumed mucous membrane pemphigoid undergoing entropion repair. Am J Ophthalmol 159:846-852.e842","journal-title":"Am J Ophthalmol"},{"key":"6756_CR125","doi-asserted-by":"publisher","first-page":"843","DOI":"10.37358\/RC.19.3.7017","volume":"70","author":"OR Ciobotaru","year":"2019","unstructured":"Ciobotaru OR, Lupu MN, Rebegea L, Ciobotaru OC, Duca OM, Tatu AL, Voinescu CD, Stoleriu G, Earar K, Miulescu M (2019) Dexamethasone-chemical structure and mechanisms of action in prophylaxis of postoperative side effects. Rev Chim (Bucharest) 70:843\u2013847","journal-title":"Rev Chim (Bucharest)"},{"key":"6756_CR126","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2496649","author":"Y He","year":"2022","unstructured":"He Y, Quan Z, Zhang R, Ji Z, Jia J, Liu H, Zhang C, He B, Ren Y, Feng Y (2022) Perioperative management and long-term outcomes in ocular cicatricial pemphigoid patients undergoing cataract surgery. Oxidative Med Cell Longev. https:\/\/doi.org\/10.1155\/2022\/2496649","journal-title":"Oxidative Med Cell Longev"},{"key":"6756_CR127","doi-asserted-by":"publisher","DOI":"10.1097\/j.jcrs.0000000000001396","author":"M Aggarwal","year":"2024","unstructured":"Aggarwal M, Gour A, Gupta N, Singh A, Sangwan V (2024) Visual outcome and postoperative complications of cataract surgery in patients with ocular surface disorders. J Cataract Refract Surg. https:\/\/doi.org\/10.1097\/j.jcrs.0000000000001396","journal-title":"J Cataract Refract Surg"},{"key":"6756_CR128","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000002211","author":"C Logioco","year":"2023","unstructured":"Logioco C, Delgado MF, Podesta N, Galetto L, Rodriguez-Libarona A, Valvecchia F, Zanutigh V (2023) MicroPulse\u00ae transscleral laser therapy (MP-TLT) in patients with glaucoma and ocular cicatricial pemphigoid. J Glaucoma. https:\/\/doi.org\/10.1097\/IJG.0000000000002211","journal-title":"J Glaucoma"},{"key":"6756_CR129","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/S0161-6420(93)31487-9","volume":"100","author":"A Heiligenhaus","year":"1993","unstructured":"Heiligenhaus A, Shore JW, Rubin PA, Foster CS (1993) Long-term results of mucous membrane grafting in ocular cicatricial pemphigoid: implications for patient selection and surgical considerations. Ophthalmology 100:1283\u20131288","journal-title":"Ophthalmology"},{"key":"6756_CR130","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1136\/bjophthalmol-2020-318547","volume":"106","author":"S Komai","year":"2022","unstructured":"Komai S, Inatomi T, Nakamura T, Ueta M, Horiguchi G, Teramukai S, Kimura Y, Kagimura T, Fukushima M, Kinoshita S (2022) Long-term outcome of cultivated oral mucosal epithelial transplantation for fornix reconstruction in chronic cicatrising diseases. Br J Ophthalmol 106:1355\u20131362","journal-title":"Br J Ophthalmol"},{"key":"6756_CR131","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/IOP.0000000000001717","volume":"37","author":"N Jovanovic","year":"2021","unstructured":"Jovanovic N, Russell WW, Heisel CJ, Hood CT, Kahana A (2021) Direct injection of 5-fluorouracil improves outcomes in cicatrizing conjunctival disorders secondary to systemic disease. Ophthalmic Plast Reconstr Surg 37:145\u2013153","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"6756_CR132","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1097\/ICO.0000000000002413","volume":"39","author":"L Camacho","year":"2020","unstructured":"Camacho L, Soldevila A, de la Paz MF (2020) Transmucosal Boston keratoprosthesis type I in a patient with advanced ocular cicatricial pemphigoid. Cornea 39:1563\u20131565","journal-title":"Cornea"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06756-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-06756-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06756-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:29:59Z","timestamp":1752139799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-06756-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":132,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["6756"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-06756-2","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"23 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a review article and does not contain any study on human or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human participants and animals"}},{"value":"This is a review article and it is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"No conflicts of interest to disclose by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}